RxDoctor Payments DataLook up a doctor →

Luis de la Cruz, MD

Sleep Medicine · Spartanburg, SCNPI 1033138912

Payments from drug & device makers

$17,584,852in general payments, 2019–2025

Across 5,717 payments — averaging $3075.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$10.3M
  • Amgen$2.5M
  • Merck$859K
  • Eli Lilly$755K
  • Boehringer Ingelheim$548K
  • GSK$532K
  • plus $2.1M from 54 others
$116,828in research payments, 2019–2025

Across 30 payments — averaging $3894.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$105K
  • Pfizer$8K
  • Chiesi USA, Inc.$2K
  • GSK$1K
  • E.r. Squibb & Sons, L.L.C.$1K

What the payments were for

  • Travel & lodging$5,06825%
  • Food & beverage$14,48173%
  • Education$3552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.4,328$10,278,256
Amgen16$2,464,227
Merck24$858,542
Eli Lilly9$755,356
Boehringer Ingelheim74$548,029
GSK189$532,030
AstraZeneca(2 entities)101$305,646
Chiesi USA, Inc.102$259,432
Mylan Specialty L.p.40$255,913
Verona Pharma, Inc.19$216,462
Amphastar Pharmaceuticals, Inc.3$194,848
Roche Diagnostics Operations, Inc.1$172,198
Teva Pharmaceuticals USA, Inc.29$151,839
Currax Pharmaceuticals LLC20$111,066
Seqirus USA Inc163$88,975
Cipla USA Inc.25$85,572
E.r. Squibb & Sons, L.L.C.4$69,762
Astrazeneca UK Limited16$48,313
Sanofi US Services Inc.17$39,216
Pfizer16$29,185
Jazz Pharmaceuticals Inc.88$27,990
CSL Behring5$23,112
Boehringer Ingelheim International GmbH45$21,425
Biohaven Pharmaceutical Holding Company Ltd.2$15,500
Novartis10$12,298
Sanofi30$7,173
Sumitomo Pharma America, Inc.5$4,900
Inspire Medical Systems, Inc.6$1,094
Electromed, Inc.49$681
Actelion Pharmaceuticals US, Inc.28$639
Regeneron Healthcare Solutions, Inc.28$613
Philips North America LLC32$602
United Therapeutics Corporation25$583
Takeda Pharmaceuticals U.S.A., Inc.23$510
Gilead26$501
Mallinckrodt Hospital Products Inc.14$320
Insmed, Inc.13$215
Sunovion Pharmaceuticals Inc.14$201
Grifols USA, LLC10$188
Edwards Lifesciences1$154
Johnson & Johnson9$141
Avadel CNS Pharmaceuticals, LLC7$131
Axsome Therapeutics, Inc.5$110
Baxter Healthcare4$106
ANI Pharmaceuticals, Inc.7$101
Genentech USA, Inc.6$101
Astrazeneca AB1$100
Bayer4$76
Harmony Biosciences LLC4$74
Resmed Corp4$60
Inogen, Inc.2$35
Advanced Respiratory, Inc2$28
Portola Pharmaceuticals, LLC1$23
Shionogi Inc1$23
Body Vision Medical Inc.1$23
Nuwellis, Inc.1$22
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$22
Lilly USA, LLC1$17
Melinta Therapeutics, LLC1$17
Vifor Pharma, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,584,852 in reported general payments places this provider in the 95th percentile of 25 sleep medicine providers in South Carolina.

See all sleep medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$179,432
Medicare patients
937
Services billed
1,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AdempasRiociguat12$169,323
XyremSodium Oxybate11$155,139
Dupixent PenDupilumab28$114,121
Trelegy ElliptaFluticasone/Umeclidin/Vilanter130$107,450
Breztri AerosphereBudesonide/Glycopyr/Formoterol118$95,009
TezspireTezepelumab-Ekko12$52,782
Breo ElliptaFluticasone/Vilanterol71$36,711
Spiriva RespimatTiotropium Bromide34$24,398
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr43$19,804
Stiolto RespimatTiotropium Br/Olodaterol Hcl25$17,204
Bevespi AerosphereGlycopyrrolate/Formoterol Fum26$12,555
Albuterol Sulfate HfaAlbuterol Sulfate437$10,714
Incruse ElliptaUmeclidinium Bromide23$8,958
SymbicortBudesonide/Formoterol Fumarate25$5,918
Fluticasone-SalmeterolFluticasone Propion/Salmeterol37$4,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$532,030$172,923267 claims
BayerAdempas$76$169,32312 claims
AstraZenecaBreztri Aerosphere, Tezspire, Bevespi Aerosphere, Symbicort$305,646$166,263181 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$548,029$41,60159 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 25 sleep medicine providers in South Carolina.

Other sleep medicine in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →